Novartis Animal Health
From DolceraWiki
Revision as of 05:59, 16 September 2011 by Abhay.goel (Talk | contribs)
Go back to homepage
| Novartis Animal Health | |
| Financial Details | |
| Total Company Revenue in 2010 | $ 50.6 Bn |
| Revenue from Animal Health Market in 2010 | $ 0.5 Bn |
| % of revenue from Animal Health in 2010 | 0.99% |
| Segmentwise Revenue Breakup ($ Bn) | |
| Livestock Vaccines | 0.375 |
| Companion Vaccines | 0.125 |
| Number of Major Vaccines (Animal-wise) | |
| Poultry | 0 |
| Swine | 0 |
| Fish | 2 |
| Sheep | 0 |
| Cattle | 1 |
| Canine | 0 |
| Feline | 0 |
| Equine | 0 |
| Mergers and Acquisitions (2009 - 2011) | Consideration |
| Chiron Behring Vaccines | $ 22.3 Mn |
| Future Focus Areas | |
| Veterinary Vaccines under trial | 1 (Rabies Vaccine - Phase III) |
| Future Focus Areas of the company in the Veterinary Vaccines Market | Want to increase their presence in vaccines |
Go back to homepage
